Amphastar Pharmaceuticals(AMPH) - 2023 Q4 - Annual Results
AMPHAmphastar Pharmaceuticals(AMPH)2024-02-28 00:00

EXHIBIT 99.1 Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023 Reports Net Revenues of 178.1MillionfortheThreeMonthsEndedDecember31,2023RANCHOCUCAMONGA,CA–February28,2024–AmphastarPharmaceuticals,Inc.(NASDAQ:AMPH)(“Amphastar”orthe“Company”)todayreportedresultsforthethreemonthsandfull−yearendedDecember31,2023.FourthQuarterHighlights●Netrevenuesof178.1 Million for the Three Months Ended December 31, 2023 RANCHO CUCAMONGA, CA – February 28, 2024 – Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months and full-year ended December 31, 2023. Fourth Quarter Highlights ● Net revenues of 178.1 million for the fourth quarter ● GAAP net income ...